Stock & Company Details
Resmed Inc. $RMD
Price:
46,691,331
145M
$28B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
30.20
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
RMD technical indicators
Latest Resmed Inc. (RMD) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
47.26 8.6%
MACD:
-1.66 6.2%
SMA 50:
$202.45 0.3%
SMA 200:
$239.79 0.2%
EMA 20:
$195.61 0.0%
Bollinger Bands:
202 / 184
Stochastic:
73.30 8.6%
ADX 14:
20.19 4.1%
ATR 14:
5.39 0.7%
CCI 20:
41.23 64.5%
OBV:
18.95M 6.2%
ROC 12:
1.29% 48.5%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Finance Bot
Ask your questions
Start by typing a question below.
